Clinical Education Hub

Oncology

Stay Informed and Earn Oncology CME Credits

The cancer treatment landscape is rapidly changing with new discoveries and expert guidance emerging. As research, testing and treatment strategies continue to evolve, clinicians must keep abreast of the latest data on molecular mechanisms, emerging therapies, current standards of care, expert guideline updates, and new strategies for treatment. Whether you are looking for education on the value and interpretation of real-world evidence for clinical decision making, translation of efficacy and safety of therapeutic agents to decisions for your patients, or resources to share with patients and families navigating their cancer journey, you’ll find educational activities and resources here to help improve your knowledge and help your patients better take part in their care.

Our activities offer many credit types, including CME, AAFP Prescribed Credit, CNE, CPE, ABIM MOC, and ABP MOC. Each activity has been designed to meet the requirements for CME for MIPS. See each activity’s information page for the exact credit type and amount of credit offered.

 

Educational Activities

Certified Activity
Non-certified Activity
Resource
Patient Education
Expired Activity
Title
Availability
Format
Credits
Launch Date
Buttons
Buttons

A Wild-Type of Approach in the First-line Treatment of HRD-Positive Advanced Ovarian Cancer

Data from recent clinical trials for first-line combination options using immunotherapies for ovarian cancer (OC) can be challenging for clinicians with no experience selecting patients for combinatorial treatment approaches or using combination therapies for their patients.  During this podcast, Drs. Richard Penson and Ramez Eskander will educate clinicians on the use of immune checkpoint inhibitors for the treatment of OC and the use of biomarker analyses to optimize patient selection.

Buttons

Up for Debate: Effective First-line Maintenance Strategies for Advanced Ovarian Cancer

Recent data has led to a debate of the most effective maintenance strategy for advanced OC. Emerging data utilizing novel approaches to maintenance both further complicates the debate and sheds new light on novel effective strategies for maintenance therapy for advanced OC, leaving clinicians struggling to adopt appropriate strategies.  In order to ensure that clinical decisions align with the latest emerging data regarding maintenance therapy in OC, Drs. Richard Penson and Kathleen Moore will educate clinicians on the role of biomarkers in OC, incorporation of genetic testing, and interpretation of results as part of clinical practice.

Buttons

Actionable Opportunities for Molecularly Classified Endometrial Cancers

Multiple clinical practice guidelines for the treatment of endometrial cancer (EC) recommend consideration of molecular testing, particularly for high-grade tumors. Yet despite its prognostic value, molecular classification is not always a part of standard risk assessment in EC. Clinical uptake has been highly variable, particularly in limited-resource areas, even though recent data shows molecular classification has value in therapeutic decision-making and is prognostic for treatment response in EC. Lack of clinical uptake has resulted in overtreatment of some EC patients and undertreatment of others.

During this informational podcast, leading national endometrial cancer experts, Drs. Richard Penson and Matthew Powell, will discuss molecular classification of EC and the clinical data supporting it’s value in EC care.

Buttons

Decoding Clinical Trial Data and Real-World Evidence in mBC, with a Focus on Individualized Care

In this 45-minute interactive CME Outfitters Snack, a diverse panel of expert faculty will discuss the evolving treatment landscape of metastatic breast cancer and how to integrate the latest clinical evidence, real world evidence, and treatment guideline recommendations to foster patient health literacy, shared-decision making, and individualized outcomes.

Buttons

Genetic Testing and Biomarkers in Cancer: A Community Oncology Approach

In the first installment of this CME Outfitters Snack series, expert faculty will guide learners through an overview of challenges and recent developments in immunotherapy, as well as guideline recommendations on their implementation in practice. Faculty will also detail strategies designed to increase implementation of best practices in genetic and biomarker testing for cancer immunotherapy.

Buttons

Genetic Counseling: Accessibility and Availability

In the second installment of this CME Outfitters Snack series, expert faculty will discuss strategies for providing high-quality genetic counseling and services for underserved patients with cancer, including leveraging health technology (e.g. telehealth), utilizing a collaborative/interprofessional approach to genetic counseling, and implementing a workable process for patient identification and triage.

Buttons

A Guide for Community Oncologists: Interpretation of Genetic and Biomarker Testing Results

In the third installment of this CME Outfitters Snack series, expert faculty will discuss the role of predictive biomarkers in guiding clinical decision-making, practical guidance for testing requirements and recommendations, and shared decision-making. Faculty will also present illustrative examples of utilizing testing to guide therapy.

Buttons

Racial and Ethnic Disparities and Health Inequities in Prostate Cancer

In this CME Outfitters podcast, expert faculty will review recent data and discuss the impact of biases, disparities, and health inequities that reduce the quality of oncology care for racial and ethnic underserved patients with prostate cancer. This program will set the stage for intervention, empowering attendees to recognize and consider factors to improve prostate cancer treatment.

Buttons

Real-world Tactics to Address Health Inequities in Prostate Cancer Care

Join a faculty expert as they guide learners through a patient case scenario reflecting the impact of biases, disparities, and health inequities that reduce the quality of care for patients with prostate cancer. This program will provide actionable strategies, empowering attendees to recognize factors and implement changes in practice to improve prostate cancer treatment.

Buttons

Real-world Tactics to Address Health Inequities in Multiple Myeloma Care

In this CME Outfitters BriefCase, faculty experts will guide learners through a patient case scenario reflecting the impact of biases, disparities, and health inequities that reduce the quality of oncology care for racial and ethnic underserved patients with multiple myeloma.

Buttons

Racial and Ethnic Disparities and Health Inequities in Lung Cancer

Join Drs. Ana I. Velázquez Mañana and Gilberto de Lima Lopes, Jr. as they review recent data and discuss the impact of biases, disparities, and health inequities that reduce the quality of oncology care for underserved racial and ethnic underserved patients with lung cancer.

Buttons

Racial and Ethnic Disparities and Health Inequities in Multiple Myeloma

In this CME Outfitters podcast, expert faculty will review recent data and discuss the sweeping impact of biases, disparities, and health inequities that reduce the quality of oncology care for racial and ethnic underserved patients with multiple myeloma.

Buttons

Real-world Tactics to Address Health Inequities in Lung Cancer Care

In this CMEO BriefCase, a faculty expert will guide learners through a patient case scenario reflecting the impact of biases, disparities, and health inequities that reduce the quality of oncology care for racial and ethnic underserved patients with lung cancer.

Buttons

Real-world Tactics to Address Health Inequities in Melanoma Care

Join a faculty expert as they guide learners through a patient case scenario reflective of the impact of biases, disparities, and health inequities that reduce the quality of oncology care for racial and ethnic underserved patients with melanoma.

Buttons

Racial and Ethnic Disparities and Health Inequities in Oncology Care

In this CME Outfitters webcast, expert faculty discuss the impact of unconscious and systemic biases, SDoH, and regional, racial, and ethnic disparities and provide tools and resources to improve oncology care for all patients.

Buttons

COMING SOON: Conversations in Gynecologic Oncology: The Experts Weigh In

Subscribe to a unique series of CMECast podcasts focused on the treatment of gynecologic cancers, in partnership with a faculty champion, Richard Penson, MD, of Harvard Medical School and Massachusetts General Hospital.